Policy and Legislation
Prince Court Medical Centre's Dr. Kuljit Singh discusses efforts to self-regulate drug price control with Malaysia's unique healthcare payment landscape.
Germany must focus on evolution over revolution in its efforts to advance healthcare digitally, but true value can only be realized with close stakeholder collaboration, says Armin Scheuer, HIMSS VP of international business development.
The FDA is also approving greater numbers of complex generic drugs, which are more difficult to replicate and traditionally lack competition.
Different states have different methods for identifying 340B drugs billed to programs, findings showed.
A limited public option that largely preserves employment-based insurance would have only a small impact, while Medicare for All is an existential threat, Moody's says.
Only 18% of the executives surveyed at U.S. healthcare companies say they are "very familiar" with new regulations.
Day one of our livestream from AsiaPac19 in Bangkok, Thailand, includes interviews with healthcare IT industry luminaries, thought leaders and innovators.
The order outlines sweeping policy and regulatory proposals including modifying Medicare fee for service payments to reflect the prices paid in MA plans and the commercial market.
The rule does not have the "vast economic and political significance" put forward by the district court as it would cost drug makers only a fraction of what they pay for TV ads, HHS says in appeal.
Health economist and writer Jane Sarasohn-Kahn discusses what it will take to move from being a health consumer to a health citizen.